Medindia

X

Patient-Specific Surgical Instrumentation Expedites Total Knee Replacement Procedures

Thursday, March 11, 2010 General News J E 4
Advertisement


WARSAW, Ind., March 10 Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal care, today showcased its recently released Zimmer® Patient Specific Instruments® (PSI) at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans.

Zimmer Patient Specific Instruments utilize MRI technology and pre-operative planning tools to create customized cutting guides that are tailored to each patient's unique anatomy. Customized guides for knee replacement surgery support surgeons in performing accurate and safe procedures. Zimmer PSI may be used in minimally-invasive procedures.

"Zimmer Patient Specific Instruments can assist in expediting the total knee replacement procedure for both surgeons and patients," said Jeff McCaulley, President, Zimmer Reconstructive. "We're excited to make these instruments available to surgeons and anticipate that PSI will become a key addition to our existing portfolio of leading technologies."

Zimmer PSI are designed to ensure accurate placement of the knee implant and are compatible with the Zimmer NexGen® Complete Knee Solution and the Gender Solutions(TM) Natural Knee® Flex systems. Zimmer PSI streamline the surgical procedure, eliminating several steps in the total knee replacement procedure and potentially increase efficiency in the operating room. The first knee implant procedures utilizing Zimmer PSI were recently completed and the products are now widely available to surgeons across the country.

For more information on Zimmer Patient Specific Instruments, visit www.zimmer.com.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2009 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Neurocrine Biosciences to Present at the Roth 22nd...
S
Battle Over Prop 17: Court Hearing and Live News C...